Clinical trial
S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer
NCT00025493 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00025493 |
|---|---|
| Title | S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer |
| Official title | Single Agent Docetaxel for Metastatic Breast Cancer in Patients Aged 70 Years and Older (and in a Cohort of Patients Younger Than 60 Years) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 27 |
| Start date | Oct 1, 2001 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 24, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: